[go: up one dir, main page]

GB1193378A - Cancer Antigen Complexes - Google Patents

Cancer Antigen Complexes

Info

Publication number
GB1193378A
GB1193378A GB02762/68A GB1276268A GB1193378A GB 1193378 A GB1193378 A GB 1193378A GB 02762/68 A GB02762/68 A GB 02762/68A GB 1276268 A GB1276268 A GB 1276268A GB 1193378 A GB1193378 A GB 1193378A
Authority
GB
United Kingdom
Prior art keywords
antigen
complex
prepared
cancer antigen
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB02762/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rand Development Corp
Original Assignee
Rand Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rand Development Corp filed Critical Rand Development Corp
Publication of GB1193378A publication Critical patent/GB1193378A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1,193,378. Cancer antigen complex. RAND DEVELOPMENT CORP. 15 March, 1968 (11 April, 11967], No. 12762/68. Heading A5B. A complex for vaccine and therapeutic treatment of cancer, comprising a water-soluble cancer antigen that is coupled to animal (e.g. rabbit, horse or sheep) gamma-globulin by bisdiazotised benzidine, is prepared by reacting the complex components together to form the complex, which is then separated. The antigen may be prepared from tumour or leukaemia tissue. The antigen may be prepared from tumour tissue by the homogenisation thereof in a mixture of water and a fluorocarbon diluent to provide an undenatured nuoleoprotein in the fluorocarbon extract comprising the antigen.
GB02762/68A 1967-04-11 1968-03-15 Cancer Antigen Complexes Expired GB1193378A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62992467A 1967-04-11 1967-04-11

Publications (1)

Publication Number Publication Date
GB1193378A true GB1193378A (en) 1970-05-28

Family

ID=24525038

Family Applications (1)

Application Number Title Priority Date Filing Date
GB02762/68A Expired GB1193378A (en) 1967-04-11 1968-03-15 Cancer Antigen Complexes

Country Status (4)

Country Link
AT (1) AT281286B (en)
DE (1) DE1767196A1 (en)
FR (1) FR7473M (en)
GB (1) GB1193378A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525475A1 (en) * 1982-04-26 1983-10-28 Otsuka Pharma Co Ltd ANTIGENS OF THE LEUKEMIA OF ADULT T CELLS, METHODS FOR THEIR PREPARATION AND FOR THE ASSAY OF ANTIBODIES AGAINST THESE ANTIGENS
US6294172B1 (en) * 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
US6926896B2 (en) 1989-03-24 2005-08-09 Aventis Pharma Deutschland Gmbh Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
US7687455B2 (en) 2004-04-13 2010-03-30 Immune Targeting Systems Ltd. Antigen delivery vectors and constructs
US8642531B2 (en) 2004-04-13 2014-02-04 Immune Targeting Systems Ltd. Influenza antigen delivery vectors and constructs

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU519008B2 (en) * 1978-04-20 1981-11-05 D. L McCOLLESTER Immunotherapy of neoplastic disease
DK292182A (en) * 1981-10-01 1983-04-02 Otsuka Pharma Co Ltd METHOD OF MANUFACTURING LYMOTOCYTES THAT ARE CYTOTOXIC TO CANCER CELLS, AND GLYCO-ASSOCIATED ANTIGEN FOR USE THEREOF
DE3513572A1 (en) * 1985-04-16 1986-10-16 Karl Prof. Dr.med. 7302 Ostfildern Theurer Preparation of products for specifically influencing the humoral and cellular immune response
DE19853206C1 (en) 1998-11-18 2000-03-23 Siemens Ag Feed-water vessel condensate warm-up device e.g. for steam electric power station

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525475A1 (en) * 1982-04-26 1983-10-28 Otsuka Pharma Co Ltd ANTIGENS OF THE LEUKEMIA OF ADULT T CELLS, METHODS FOR THEIR PREPARATION AND FOR THE ASSAY OF ANTIBODIES AGAINST THESE ANTIGENS
US6294172B1 (en) * 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
US6926896B2 (en) 1989-03-24 2005-08-09 Aventis Pharma Deutschland Gmbh Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
US7662383B2 (en) 1989-03-24 2010-02-16 Aventis Pharma Deutschland Gmbh Chimeric antibody against tumor associated antigens and its use in diagnosing tumors
US8110540B2 (en) 2004-04-13 2012-02-07 Immune Targeting Systems Ltd. Antigen delivery vectors and constructs
EP2374477A1 (en) * 2004-04-13 2011-10-12 Immune Targeting Systems Antigen delivery vectors and constructs
US7687455B2 (en) 2004-04-13 2010-03-30 Immune Targeting Systems Ltd. Antigen delivery vectors and constructs
US8129333B2 (en) 2004-04-13 2012-03-06 Immune Targeting Systems Ltd. Antigen delivery vectors and constructs
US8642531B2 (en) 2004-04-13 2014-02-04 Immune Targeting Systems Ltd. Influenza antigen delivery vectors and constructs
US8759281B2 (en) 2004-04-13 2014-06-24 Immune Targeting Systems Ltd. Antigen delivery vectors and constructs
US11066353B2 (en) 2004-04-13 2021-07-20 Altimmune Uk Ltd Antigen delivery vectors and constructs
US9446143B2 (en) 2007-08-31 2016-09-20 Altimmune Uk Limited Influenza antigen delivery vectors and constructs
US10155049B2 (en) 2007-08-31 2018-12-18 Altimmune UK, LTD Influenza antigen delivery vectors and constructs

Also Published As

Publication number Publication date
FR7473M (en) 1969-12-01
DE1767196A1 (en) 1972-07-06
AT281286B (en) 1970-05-11

Similar Documents

Publication Publication Date Title
Yen Identification of landmarks in cephalometric radiographs
GB1193378A (en) Cancer Antigen Complexes
GB758819A (en) Improvements in fencing posts
GB1375004A (en)
ES397459A1 (en) Process for extracting therapeutic substances
USD166864S (en) Nve ntor c. mecum by
Tomomatsu A serological study of experimental dermatomycoses, using an antigen prepared from fungus mechanically disintegrated. V. Production of humoral antibody and skin hypersensitivity in test-animals and man during griseofulvin-therapy
USD183073S (en) Self-propelled swather
ES230912A1 (en) Procedure for the obtaining of inspiid preparations of basic antihistamines (Machine-translation by Google Translate, not legally binding)
GB1024369A (en) Antiserum preparations
ES207753A1 (en) A procedure for the preparation of valuable product from the therapeutic viewpoint (Machine-translation by Google Translate, not legally binding)
GB1198280A (en) Production of Antibodies
ES331775A1 (en) A procedure to improve the properties of foaming agents. (Machine-translation by Google Translate, not legally binding)
GB913235A (en) Improvements in or relating to devices for the lateral displacement of crop lying onthe ground
ES212708A1 (en) A procedure for the obtaining of active pharmaceutical preparations as antiacides (Machine-translation by Google Translate, not legally binding)
GB821921A (en) Improvements in or relating to process for preparing vaccines for preventing and combating malign tumors
ES275850A3 (en) Procedure for the preparation of ammoniaced food for livestock (Machine-translation by Google Translate, not legally binding)
ES132637U (en) New variety of griºonero. (Machine-translation by Google Translate, not legally binding)
Honda et al. A Case of Bone Cyst, Treated by the Implantation of Fresh Homogenous Bone Chips
ES9557U (en) Special device for joining the sole to wooden parts for footwear. (Machine-translation by Google Translate, not legally binding)
ES264140A1 (en) New procedure for the obtaining of rubber aros without central seaming, applicable to toys (Machine-translation by Google Translate, not legally binding)
ES14389Y (en) Special card for annotations and propaganda.
ES255146A3 (en) Method of preparation of effective immunizing antigens in vaccination of cattle (Machine-translation by Google Translate, not legally binding)
GR23080B (en) NEW SPIRAMYCINE SALTS AND ANIMAL FEED PRODUCT CONTAINS THESE SALTS.
ES214146A1 (en) A new method for vaccination (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLE Entries relating assignments, transmissions, licences in the register of patents
PCNP Patent ceased through non-payment of renewal fee